Chemical Property of A77 1726
Chemical Property:
- Appearance/Colour:White solid.
- Vapor Pressure:6.63E-06mmHg at 25°C
- Melting Point:229-232°C
- Boiling Point:410.8 °C at 760 mmHg
- PKA:5.20±0.50(Predicted)
- Flash Point:202.3 °C
- PSA:73.12000
- Density:1.424 g/cm3
- LogP:3.07248
- Storage Temp.:+2C to +8C
- Solubility.:Soluble in DMSO (up to 30 mg/ml), or in Ethanol (up to 5 mg/ml with warming).
- Purity/Quality:
-
99% *data from raw suppliers
Teriflunomide *data from reagent suppliers
Safty Information:
- Pictogram(s):
Xn
- Hazard Codes:Xn
- Statements:
22
- MSDS Files:
-
SDS file from LookChem
Useful:
-
Description
Teriflunomide (Aubagio?), also known as A77 1726, is an immunosupressant marketed by Sanofi for
the teatment of multiple sclerosis (MS). Teriflunomide is the active metabolite of leflunomide, used
for treatment of patients diagnosed with rheumatoid arthritis, and therefore simultaneously can be used
as a treatment for rheumatoid arthritis.Teriflunomide acts as an inhibitor of the mitochondrial
enzyme dihydrorotate dehydrogenase, inhibiting pyrimidine formation, and resulting in reduced
B and T cell proliferation.
-
Uses
The active metabolite of Leflunomide, 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide can be used as a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis.
-
Clinical Use
Immunomodulating agent:
Treatment of relapsing remitting multiple sclerosis
-
Drug interactions
Potentially hazardous interactions with other drugs
Lipid-lowering agents: effect significantly reduced by
colestyramine - avoid; concentration of rosuvastatin
increased - consider reducing rosuvastatin dose.
Live vaccines: risk of generalised infections - avoid.